Published in PLoS One on December 20, 2006
Tailoring to RB: tumour suppressor status and therapeutic response. Nat Rev Cancer (2008) 3.16
Structure-function analysis of the retinoblastoma tumor suppressor protein - is the whole a sum of its parts? Cell Div (2007) 1.22
RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy. Oncotarget (2015) 1.20
SerpinB2 protection of retinoblastoma protein from calpain enhances tumor cell survival. Cancer Res (2008) 1.16
Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells. J Virol (2011) 1.12
p38 phosphorylates Rb on Ser567 by a novel, cell cycle-independent mechanism that triggers Rb-Hdm2 interaction and apoptosis. Oncogene (2010) 1.06
DNA damage signals through differentially modified E2F1 molecules to induce apoptosis. Mol Cell Biol (2011) 1.03
A retinoblastoma allele that is mutated at its common E2F interaction site inhibits cell proliferation in gene-targeted mice. Mol Cell Biol (2014) 0.95
Human herpesvirus 6A (HHV-6A) and HHV-6B alter E2F1/Rb pathways and E2F1 localization and cause cell cycle arrest in infected T cells. J Virol (2007) 0.87
pRB-E2F1 complexes are resistant to adenovirus E1A-mediated disruption. J Virol (2008) 0.86
Retinoblastoma protein regulates the crosstalk between autophagy and apoptosis, and favors glioblastoma resistance to etoposide. Cell Death Dis (2013) 0.86
The molecular genetics of breast cancer and targeted therapy. Biologics (2007) 0.81
Next-generation sequencing-based method shows increased mutation detection sensitivity in an Indian retinoblastoma cohort. Mol Vis (2016) 0.75
The hallmarks of cancer. Cell (2000) 113.05
A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A (1998) 24.58
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell (1992) 9.19
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell (1992) 7.61
Isolation and regional localization of DNA segments revealing polymorphic loci from human chromosome 13. Am J Hum Genet (1984) 3.86
E2F target genes: unraveling the biology. Trends Biochem Sci (2004) 3.49
Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature (1998) 3.01
A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell (1993) 2.80
E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc Natl Acad Sci U S A (1993) 2.61
pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc Natl Acad Sci U S A (1998) 2.49
Homozygosity of chromosome 13 in retinoblastoma. N Engl J Med (1984) 2.49
The genetics of the E2F family of transcription factors: shared functions and unique roles. Biochim Biophys Acta (2002) 2.47
Coordinated regulation of life and death by RB. Nat Rev Cancer (2003) 2.39
Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc Natl Acad Sci U S A (1991) 2.26
Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol Cell Biol (1997) 2.25
Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J Biol Chem (1996) 2.23
RB-dependent S-phase response to DNA damage. Mol Cell Biol (2000) 2.08
Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression. Genes Dev (1998) 1.99
Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release. Cell (2005) 1.90
BRG-1 is required for RB-mediated cell cycle arrest. Proc Natl Acad Sci U S A (2000) 1.85
Regulation of cell death by the Abl tyrosine kinase. Oncogene (2000) 1.81
pRB contains an E2F1-specific binding domain that allows E2F1-induced apoptosis to be regulated separately from other E2F activities. Mol Cell (2003) 1.77
Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation. Proc Natl Acad Sci U S A (2003) 1.68
Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins. Mol Cell Biol (2000) 1.66
Inhibition of apoptosis by the retinoblastoma gene product. EMBO J (1995) 1.58
The retinoblastoma tumor-suppressor gene, the exception that proves the rule. Oncogene (2006) 1.41
E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol Cell (1999) 1.34
Active repression and E2F inhibition by pRB are biochemically distinguishable. Genes Dev (2001) 1.22
Growth suppression by an E2F-binding-defective retinoblastoma protein (RB): contribution from the RB C pocket. Mol Cell Biol (1998) 1.19
Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function. Mol Cell Biol (2000) 1.19
Nucleo-cytoplasmic communication in apoptotic response to genotoxic and inflammatory stress. Cell Res (2005) 1.07
The retinoblastoma tumor suppressor protein is required for efficient processing and repair of trapped topoisomerase II-DNA-cleavable complexes. Oncogene (2005) 0.91
Active RB elicits late G1/S inhibition. Exp Cell Res (2002) 0.89
Phosphorylation site mutated RB exerts contrasting effects on apoptotic response to different stimuli. Oncogene (2006) 0.86
Coordinated regulation of life and death by RB. Nat Rev Cancer (2003) 2.39
Regulation of F-actin-dependent processes by the Abl family of tyrosine kinases. J Cell Sci (2003) 2.10
Modulation of the F-actin cytoskeleton by c-Abl tyrosine kinase in cell spreading and neurite extension. J Cell Biol (2002) 1.72
Targeting the RB-pathway in cancer therapy. Clin Cancer Res (2010) 1.54
Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics. Int J Cancer (2006) 1.53
A myogenic differentiation checkpoint activated by genotoxic stress. Nat Genet (2002) 1.53
Double-strand DNA breaks recruit the centromeric histone CENP-A. Proc Natl Acad Sci U S A (2009) 1.47
Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc Natl Acad Sci U S A (2003) 1.47
Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage. Mol Cell Biol (2006) 1.45
BCR-ABL-transformed GMP as myeloid leukemic stem cells. Proc Natl Acad Sci U S A (2008) 1.34
c-Abl phosphorylates Dok1 to promote filopodia during cell spreading. J Cell Biol (2004) 1.26
Selection of mammalian cells based on their cell-cycle phase using dielectrophoresis. Proc Natl Acad Sci U S A (2007) 1.23
Signal-dependent protection from apoptosis in mice expressing caspase-resistant Rb. Nat Cell Biol (2002) 1.22
RB restricts DNA damage-initiated tumorigenesis through an LXCXE-dependent mechanism of transcriptional control. Mol Cell (2011) 1.16
Induction of cell retraction by the combined actions of Abl-CrkII and Rho-ROCK1 signaling. J Cell Biol (2008) 1.13
Modulation of DNA damage-induced apoptosis by cell adhesion is independently mediated by p53 and c-Abl. Proc Natl Acad Sci U S A (2003) 1.12
The CML stem cell: evolution of the progenitor. Cell Cycle (2009) 1.10
Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy. Int J Hematol (2008) 1.00
Abl tyrosine kinase promotes dorsal ruffles but restrains lamellipodia extension during cell spreading on fibronectin. Mol Biol Cell (2007) 1.00
Tumor necrosis factor alpha-induced apoptosis requires p73 and c-ABL activation downstream of RB degradation. Mol Cell Biol (2004) 1.00
cAMP-mediated inhibition of DNA replication and S phase progression: involvement of Rb, p21Cip1, and PCNA. Mol Biol Cell (2005) 0.97
A functional connection between pRB and transforming growth factor beta in growth inhibition and mammary gland development. Mol Cell Biol (2009) 0.97
Ascorbate up-regulates MLH1 (Mut L homologue-1) and p73: implications for the cellular response to DNA damage. Biochem J (2002) 0.96
Tumor promotion by caspase-resistant retinoblastoma protein. Proc Natl Acad Sci U S A (2005) 0.94
Blockade of tumor necrosis factor-induced Bid cleavage by caspase-resistant Rb. J Biol Chem (2007) 0.93
An evolutionarily acquired genotoxic response discriminates MyoD from Myf5, and differentially regulates hypaxial and epaxial myogenesis. EMBO Rep (2011) 0.92
Death by Abl: a matter of location. Curr Top Dev Biol (2004) 0.92
Ionizing radiation induces ATM-independent degradation of p21Cip1 in transformed cells. J Biol Chem (2009) 0.91
DNA damage-induced cell death: lessons from the central nervous system. Cell Res (2008) 0.91
Exclusion of c-Abl from the nucleus restrains the p73 tumor suppression function. J Biol Chem (2003) 0.91
Interplay between kinase domain autophosphorylation and F-actin binding domain in regulating imatinib sensitivity and nuclear import of BCR-ABL. PLoS One (2011) 0.90
Radiation dose-dependent maintenance of G(2) arrest requires retinoblastoma protein. Cell Cycle (2002) 0.89
Modulation of human checkpoint kinase Chk1 by the regulatory beta-subunit of protein kinase CK2. Oncogene (2003) 0.87
Apoptotic function of human PMS2 compromised by the nonsynonymous single-nucleotide polymorphic variant R20Q. Proc Natl Acad Sci U S A (2008) 0.87
Trp53 deficiency protects against acute intestinal inflammation. J Immunol (2013) 0.86
Murine xenograft model for human uterine fibroids: an in vivo imaging approach. Reprod Sci (2009) 0.85
Systems analysis of quantitative shRNA-library screens identifies regulators of cell adhesion. BMC Syst Biol (2008) 0.84
Uracil DNA N-glycosylase promotes assembly of human centromere protein A. PLoS One (2011) 0.84
Eph tumour suppression: the dark side of Gleevec. Nat Cell Biol (2006) 0.83
Platelet-derived growth factor C is upregulated in human uterine fibroids and regulates uterine smooth muscle cell growth. Biol Reprod (2009) 0.83
Nuclear expression of β-catenin promotes RB stability and resistance to TNF-induced apoptosis in colon cancer cells. Mol Cancer Res (2013) 0.83
Exploiting the promiscuity of imatinib. J Biol (2009) 0.82
Mitotic phosphorylation rescues Abl from F-actin-mediated inhibition. J Biol Chem (2005) 0.82
Persistent inhibition of ABL tyrosine kinase causes enhanced apoptotic response to TRAIL and disrupts the pro-apoptotic effect of chloroquine. PLoS One (2013) 0.81
β-Catenin-dependent lysosomal targeting of internalized tumor necrosis factor-α suppresses caspase-8 activation in apoptosis-resistant colon cancer cells. Mol Biol Cell (2012) 0.81
Ectopic expression of p73alpha, but not p73beta, suppresses myogenic differentiation. J Biol Chem (2004) 0.81
Reduced focal adhesion kinase and paxillin phosphorylation in BCR-ABL-transfected cells. Cancer (2002) 0.80
Expression profiling of protein tyrosine kinases and their ligand activators in leiomyoma uteri. Syst Biol Reprod Med (2010) 0.79
Effect of hydroxyurea on the promoter occupancy profiles of tumor suppressor p53 and p73. BMC Biol (2009) 0.75